Skip to main content
Caplight Logo









RS Research

RS Research

Private
TurkeyHealthcare & Life Scienceshttps://rsresearch.net/

Last Round

Series A

Dec 15, 2021

Total Funding Raised

$14.16M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

RS Research is a drug discovery company that develops targeted oncology therapies using its proprietary drug-delivery platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformpolymer-drug conjugatesnanomedicinetargeted chemotherapyoncology therapiesclinical-stage biotechdrug candidate pipelinetheranosticsPDCsolid tumor treatmentGMP manufacturingpreclinical servicesradioligand therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RS Research Comparables

Compare RS Research with similar companies based on industry and business-model similarity.

RS Research comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cybrexa Therapeutics
82%
OncoNano Medicine
79%
Avacta Group
77%

RS Research Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 15, 2021
SeedApr 21, 2017

Key People

Founding team and executive leadership

Sena Nomak

Co-Founder COO

Founding Team

RS Research Investors

Notable investors and investment history

RS Research investors
InvestorRounds
Eczacıbaşı MomentumSeries A
ACT Venture PartnersSeries A, Seed
İstanbul Portföy YönetimiSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 8, representing 28% of headcount.

  • Jun 1, 2025

    Monthly visitors grew 159% MoM, from 285 to 739.

RS Research Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RS Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RS Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersTurkey
Employee Range29
Year Founded2015
Last FundingDec 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?